RPS29P15

Across TCGA pan-cancer cohorts, RPS29P15 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RPS29P15 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RPS29P15 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS29P15 expression acts as an unfavorable survival marker, although some lineages such as BLCA and UVM show a favorable association.

MESO, BLCA, and UVM are the cancer types where RPS29P15 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	II,III,IV	0.398	0.624	<.001	130	view →
BLCA	OS	Tertile	All	0.897	0.518	.003	39	view →
UVM	OS	Tertile	All	0.821	0.456	.005	34	view →
BRCA	DFS	Tertile	All	0.497	0.533	.022	30	view →
DLBC	DFS	Quartile	IV	0.136	0.856	.010	30	view →
LUSC	OS	Tertile	IV	0.001	0.651	.025	27	view →
KIRC	DFS	Tertile	IV	0.221	0.603	.046	18	view →
TGCT	OS	Tertile	All	0.851	0.976	.002	18	view →
PRAD	DFS	Tertile	All	0.919	0.937	.029	18	view →
THYM	DFS	Tertile	II,III,IV	1.000	0.551	.009	9	view →
LAML	DFS	Median	All	0.256	0.542	.017	4	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RPS29P15–MESO (OS)

Open the MESO breakdown →